Search results
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 1 hour ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Novavax Stock More Than Doubles After $1.4 Billion Vaccine-Licensing Deal with Sanofi
The Wall Street Journal· 2 hours agoShares in Novavax (NVAX) surged after the vaccine maker said it had struck a $1.4 billion licensing...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 2 hours agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 2 hours agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
Barrons.com· 2 hours agoNovavax the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine...
French, US drug firms team up for Covid-flu shot
Medical Xpress· 3 hours agoUnder a licensing deal worth up to $1.2 billion, the companies will co-commercialize Novavax's COVID-19 vaccine worldwide, except in some countries...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 6 hours agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 3 hours agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 10 hours agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Novavax Stock More Than Doubles On Deal With Sanofi To Co-commercialize Covid-19 Vaccine
RTT News· 2 hours agoNovavax also announced a co-exclusive licensing agreement with Sanofi to co-commercialize Covid-19 vaccine and develop Novel Covid-19-Influenza combination ...